Systematic evaluation of economic evaluations of Nivolumab and Pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma

DU Yi, YANG Fan, JIANG Rong, SHEN Jian, SHAO Rong

Chinese Journal of Hospital Pharmacy ›› 2024, Vol. 44 ›› Issue (4) : 441-446.

PDF(475 KB)
PDF(475 KB)
Chinese Journal of Hospital Pharmacy ›› 2024, Vol. 44 ›› Issue (4) : 441-446. DOI: 10.13286/j.1001-5213.2024.04.12
Drug and Clinical

Systematic evaluation of economic evaluations of Nivolumab and Pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 44(4): 441-446 https://doi.org/10.13286/j.1001-5213.2024.04.12

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(475 KB)

Accesses

Citation

Detail

Sections
Recommended

/